Efficacy and Safety of VDPHL01 in Males With AGA

NCT06724614 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenetic Alopecia
AGA
Male Pattern Baldness

Interventions

DRUG: VDPHL01
DRUG: Placebo

Sponsor

Veradermics, Inc.